Maranduca, M.A.; Tanase, D.M.; Cozma, C.T.; Dima, N.; Clim, A.; Pinzariu, A.C.; Serban, D.N.; Serban, I.L.
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences. Pharmaceutics 2022, 14, 1906.
https://doi.org/10.3390/pharmaceutics14091906
AMA Style
Maranduca MA, Tanase DM, Cozma CT, Dima N, Clim A, Pinzariu AC, Serban DN, Serban IL.
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences. Pharmaceutics. 2022; 14(9):1906.
https://doi.org/10.3390/pharmaceutics14091906
Chicago/Turabian Style
Maranduca, Minela Aida, Daniela Maria Tanase, Cristian Tudor Cozma, Nicoleta Dima, Andreea Clim, Alin Constantin Pinzariu, Dragomir Nicolae Serban, and Ionela Lacramioara Serban.
2022. "The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences" Pharmaceutics 14, no. 9: 1906.
https://doi.org/10.3390/pharmaceutics14091906
APA Style
Maranduca, M. A., Tanase, D. M., Cozma, C. T., Dima, N., Clim, A., Pinzariu, A. C., Serban, D. N., & Serban, I. L.
(2022). The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences. Pharmaceutics, 14(9), 1906.
https://doi.org/10.3390/pharmaceutics14091906